Drzezga, Alexander http://orcid.org/0000-0001-6018-716X
,
Altomare, Daniele
Festari, Cristina
Arbizu, Javier
Orini, Stefania
Herholz, Karl
Nestor, Peter
Agosta, Federica
Bouwman, Femke
Nobili, Flavio
Walker, Zuzana
Frisoni, Giovanni Battista
Boccardi, Marina
Article History
Received: 11 April 2018
Accepted: 16 April 2018
First Online: 13 May 2018
Compliance with ethical standards
:
: Flavio Nobili: received personal fees and non-financial support from GE Healthcare, non-financial support from Eli-Lilly, and grants from Chiesi Farmaceutici.Cristina Festari: declares that she has no conflict of interest.Daniele Altomare: was the recipient of the grant allocated by the European Academy of Neurology (EAN) for data extraction and evidence assessment for the present project.Federica Agosta: is Section Editor of NeuroImage Clinical; has received speaker fees from Biogen Idec, Novartis, and Excellence in Medical Education; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. She received personal fees from Elsevier INC.Stefania Orini:: declares that she has no conflict of interest.Federica Gandolfo: declares that she has no conflict of interest.Javier Arbizu: received grants from Eli-Lilly & Co, Piramal and GE Healthcare.Femke Bouwman: none.Peter Nestor: none.Alexander Drzezga: received grants and non-financial support from Eli-Lilly & Co, Siemens, and GE Healthcare; he also received non-financial support from Piramal.Zuzana Walker: received from GE Healthcare grants and tracers, personal fees for consultancy, and speakers fee.Marina Boccardi: has received funds from the European Association of Nuclear Medicine (EANM) to perform the evidence assessment and the global coordination of the present project. Moreover, she has received research grants from Piramal, and served as a paid member of advisory boards for Eli Lilly.Giovanni B Frisoni: is principal investigator of industry-sponsored trials funded by AbbVie, Acadia, Altoida, Amoneta, Araclon, Biogen, Janssen, Novartis, Piramal; has received funding for investigator-initiated trials from GE, Piramal, and Avid-Lilly; has received speaker fees from a number of pharma and imaging companies.
: This is a review article that does not contain any original study with human participants performed by any of the authors. Ethical approval is shown in each of the quoted original paper.
: Not applicable, this is a review article. Informed consent statement is declared in each of the revised paper.